Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...

A new version of Cellpose —the popular tool that maps the boundaries of diverse cells in microscopy images —now works on less-than-perfect pictures that are noisy, blurry, or undersampled.

Cancer models developed with 3D bioprinting technology allow for rapid evaluation of individual drug responses.

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The ...

An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

arises from the intricate interactions between cerebral blood vessels and neural cells, where the BBB plays a pivotal regulatory role. However, existing BBB models have been unable to replicate the ...

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...

Research found that ibrutinib reduces red blood cell aggregation in patients with ... aggregation than healthy controls, forming complex 3D clusters. This altered blood viscosity could contribute ...

Aston Martin Lagonda Global Holdings Plc designs, creates, and exports cars. Its sports cars are manufactured in Gaydon with its luxury DBX SUV range manufactured in St. Athan, Wales. The company ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...